MMR: Winning the battle for hearts and minds Community pharmacy is in a prime position to help refute damaging anti-vaccination myths and, as a direct result, could save lives.…
Majority of oral medications contain ingredients that could cause an allergic reaction, study finds More than 90% of oral medications frequently prescribed in the United States contain inactive ingredients that could cause adverse reactions.…
Supply of adrenaline auto-injectors returns to normal The interim protocol for the dispensing of adrenaline 150 microgram auto-injectors will cease to be in effect from 29 November 2018, the NHS has said.…
Researchers make breakthrough in potential treatment for peanut allergy Children and young people with peanut allergy may be able to protect themselves from accidental ingestion by building up their tolerance to peanut protein over time, a study published in the New England Journal of Medicine has shown.…
Parents advised to use out-of-date EpiPens, but call 999, as shortage continues NHS England has written to parents and carers of children that use EpiPen Jr, advising on them on what to do in the event of a severe allergic or anaphylactic reaction as the shortage of EpiPens continues…
Coroner calls on MHRA to take action over ‘inherently unsafe’ EpiPen The coroner who investigated the death of Natasha Ednan-Laperouse has said the EpiPen’s “inadequate dose of adrenaline for anaphylaxis and an inadequate length needle” raises serious safety concerns.…
Pharmacists face continued EpiPen shortages Pharmacists in the UK are having to ration stocks of EpiPen, a first-line treatment for anaphylaxis, as a result of ongoing shortages.…
Leading brand of condoms recalled after failing required safety standards Specific batches of Durex condoms are being recalled after they failed to pass required safety standards.…
More than 40 hay fever risk genes uncovered by international study Researchers have discovered more than 40 risk genes associated with hay fever, including 20 not previously known about.…
New drug could reduce symptoms of gluten exposure in people with coeliac disease A monoclonal antibody could help reduce symptoms of coeliac disease in people with the condition who are accidentally exposed to gluten, show study findings presented at Digestive Disease Week.…
